ZA200707572B - Use of an artificial sweetener to enhance absorption of nicotine - Google Patents

Use of an artificial sweetener to enhance absorption of nicotine

Info

Publication number
ZA200707572B
ZA200707572B ZA200707572A ZA200707572A ZA200707572B ZA 200707572 B ZA200707572 B ZA 200707572B ZA 200707572 A ZA200707572 A ZA 200707572A ZA 200707572 A ZA200707572 A ZA 200707572A ZA 200707572 B ZA200707572 B ZA 200707572B
Authority
ZA
South Africa
Prior art keywords
nicotine
artificial sweetener
enhance absorption
enhance
absorption
Prior art date
Application number
ZA200707572A
Other languages
English (en)
Inventor
Axelsson Anders
Original Assignee
Niconovum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Niconovum Ab filed Critical Niconovum Ab
Publication of ZA200707572B publication Critical patent/ZA200707572B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Luminescent Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
ZA200707572A 2005-03-22 2007-09-03 Use of an artificial sweetener to enhance absorption of nicotine ZA200707572B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200500414 2005-03-22

Publications (1)

Publication Number Publication Date
ZA200707572B true ZA200707572B (en) 2009-08-26

Family

ID=34979969

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200707572A ZA200707572B (en) 2005-03-22 2007-09-03 Use of an artificial sweetener to enhance absorption of nicotine

Country Status (6)

Country Link
US (1) US20090023819A1 (xx)
EP (1) EP1885332A2 (xx)
AU (1) AU2006226509A1 (xx)
IL (1) IL185767A0 (xx)
WO (1) WO2006100075A2 (xx)
ZA (1) ZA200707572B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US20140166028A1 (en) * 2012-12-14 2014-06-19 Richard C. Fuisz Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor or Smoke Producing Device Through Use of an Absorption Conditioning Unit
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
MX2015015175A (es) * 2013-05-06 2016-01-12 Pax Labs Inc Formulaciones de sal de nicotina para dispositivos de aerosol y metodos de los mismos.
EP3076805A4 (en) 2013-12-05 2017-10-11 PAX Labs, Inc. Nicotine liquid formulations for aerosol devices and methods thereof
US20170172938A1 (en) * 2014-07-08 2017-06-22 Fertin Pharma A/S Oral delivery system comprising two compartments
AU2015336216B2 (en) * 2014-10-20 2020-05-21 Oyster Point Pharma, Inc. Methods of treating ocular conditions
GB2535427A (en) 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
CA2914089C (en) 2015-12-03 2018-12-18 Euro-Pharm International Canada Inc. Nicotine-containing liquid formulations and uses thereof
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
CA2916077C (en) * 2015-12-22 2023-06-20 Euro-Pharm International Canada Inc. Nicotine-containing solid oral formulations and uses thereof
TW202320785A (zh) 2016-04-07 2023-06-01 美商奧伊斯特普安生物製藥公司 治療眼部病狀之方法
EP3807260A1 (en) 2018-06-15 2021-04-21 R. J. Reynolds Tobacco Company Purification of nicotine
US11883527B2 (en) 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture
EP4072516A1 (en) 2019-12-09 2022-10-19 Nicoventures Trading Limited Oral product comprising a cannabinoid
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
US11672862B2 (en) 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1528391A (en) * 1976-01-05 1978-10-11 Gildemeister V Aerosol compositions
US4624269A (en) * 1984-09-17 1986-11-25 The Pinkerton Tobacco Company Chewable tobacco based product
US4853247A (en) * 1987-06-16 1989-08-01 Warner-Lambert Co. Taste and odor masked edible oil compositions
US6024097A (en) * 1992-02-20 2000-02-15 J Mom Trust Product for assisting a smoker in giving up the habit
US5810018A (en) * 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
DE10013712A1 (de) * 2000-03-20 2001-09-27 Nutrinova Gmbh Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20030171408A1 (en) * 2002-03-11 2003-09-11 Caplan Jay L. Therapeutic method of delivering a medicament to avoid irritating effects on membranes of user

Also Published As

Publication number Publication date
IL185767A0 (en) 2008-01-06
WO2006100075A2 (en) 2006-09-28
WO2006100075A3 (en) 2007-04-05
US20090023819A1 (en) 2009-01-22
EP1885332A2 (en) 2008-02-13
AU2006226509A1 (en) 2006-09-28
WO2006100075A8 (en) 2007-11-15

Similar Documents

Publication Publication Date Title
IL185767A0 (en) Use of an artificial sweetener to enhance absorption of nicotine
IL189602A0 (en) Indenoisoquinolinone analogs and methods of use thereof
EP1874731A4 (en) CHINOBENZOXAZINANALOGA AND METHOD FOR THE APPLICATION
HK1117519A1 (en) Substituted benzimidazoles and methods of preparation
EP1871761A4 (en) SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHOD FOR THEIR USE
PL2049127T3 (pl) N-metanokarbapochodne do leczenia chorób serca
IL185097A0 (en) Tissue specific expression of antibodies in chickens
EP2006271A4 (en) SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF
ZA200804688B (en) Purine derivatives and methods of use thereof
HK1108614A1 (en) Human body composition analyzer
HK1161122A1 (en) Use of 24-norudca 24-norudca
EP1926824A4 (en) METHOD FOR DETERMINING REACTIVITY TO ERYTROPOIETIN TREATMENT
IL192953A0 (en) Methods to use 3-pyridyl derivatives as pesticides
EP1977003A4 (en) DISEASE-RELATED METHODS AND MEDIUM
IL196320A0 (en) Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
GB0515325D0 (en) Improvements relating to the detection of lower limb disease
EP2066171A4 (en) ADMINISTERING A TREATMENT SUBSTANCE TO POROUS ELEMENTS
EP1931370A4 (en) USE OF DES-ASPARTATE-ANGIOTENSIN I
GB0410586D0 (en) Improvements relating to patient turning devices
ZA200709307B (en) Spirocyclic heterocyclic derivatives and methods of their use
TWI367323B (en) Method to measure the concentration of inhibiter
GB0413668D0 (en) Improvements to cannula components
GB0428268D0 (en) Pulsing wristband to induce sleep
GB0526264D0 (en) Improvements to the tappping of small holes
GB2405594B (en) Improvements relating to nebulisers